Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.49 CAD | +3.41% |
|
+4.18% | -11.65% |
06-07 | Transcript : HLS Therapeutics Inc. - Shareholder/Analyst Call | |
05-28 | HLS Therapeutics Notes Role of Pharmaceutical Support Programs on Persistence with Clozapine Treatment in Quebec Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.65% | 81.25M | |
+30.55% | 78.4B | |
+2.31% | 25.12B | |
+12.73% | 8.62B | |
+2.44% | 8.55B | |
-30.63% | 6.91B | |
+17.58% | 5.34B | |
+2.75% | 4.17B | |
-9.01% | 3.82B | |
+9.64% | 3.26B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- HLS Therapeutics Up 3% As Announces Retirement Of 2 Board Directors, Strikes Agreement with Polar Asset Management Partners